MIRA INFORM REPORT

 

 

Report No. :

342091

Report Date :

29.09.2015

 

 

IDENTIFICATION DETAILS

 

Name :

ARYSTA LIFESCIENCE INDIA LIMITED

 

 

Formerly Known As :

DEVIDAYAL SALES LIMITED

 

 

Registered Office :

123-124, 12th Floor, Mittal Chambers, Nariman Point, Mumbai – 400021, Maharashtra

Tel. No.:

91-22-61843333

 

 

Country :

India

 

 

Financials (as on) :

31.03.2014

 

 

Date of Incorporation :

07.11.1949

 

 

Com. Reg. No.:

11-007856

 

 

Capital Investment / Paid-up Capital :

Rs. 28.771 Million

 

 

CIN No.:

[Company Identification No.]

U51420MH1949PLC007856

 

 

IEC No.:

0388005947

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

AAACD0557C

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Manufacturer of Products related to Agrochemicals, Veterinary Chemicals and Pesticides.

 

 

No. of Employees :

500 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (47)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

 

Maximum Credit Limit :

USD 2400000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually Correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is a subsidiary of “Arysta Lifescience (Mauritius) Limited”. It is an established company incorporated in the year 1949 having satisfactory track record.

 

Subject is engaged in the business as manufacturer of products related to agrochemicals, veterinary chemicals and pesticides.

 

Profit margin of the company is low. However, net worth position of the company is sound. Overall financial position of the company is healthy.

 

The company also receives strong operational and managerial support from its holding company.

 

Further, the rating also takes into consideration rich experience of its promoters, long track record and good operating efficiency of the company.

 

Trade relations are reported as fair. Business is active. Payments terms are reported as usually correct and as per commitments.

 

The company can be considered normal for business dealings at usual trade terms and conditions.

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31, 2015

 

Country Name

Previous Rating

(31.12.2014)

Current Rating

(31.03.2015)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

EXTERNAL AGENCY RATING

 

Not Available

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2015.

 

 

INFORMATION PARTED BY

 

Name :

Mr. Rajeev Gupta

Designation :

Account Manager

Contact No.:

91-22-61843333

Date :

23.09.2015

 

 

LOCATIONS

 

Registered Office :

123-124, 12th Floor, Mittal Chambers, Nariman Point, Mumbai – 400021, Maharashtra, India

Tel. No.:

91-22-61843333

E-Mail :

Rajeev.gupta@arysta.com

Website :

www.arystalifescience.com 

Area :

4000 Sq. Ft. (Approximately)

Location :

Owned

Locality :

Commercial

 

 

Head Office :

50/A, GIDC Industrial Estate, Kalol – 389330, Gujarat, India

 

 

DIRECTORS

 

AS ON 30.09.2014

 

Name :

Ganeshkumar Subramanian

Designation :

Managing Director

Address :

HIB-144 , Westend Heights, DLF City, Phase V, Gurgaon - 122009, Haryana, India

Date of Birth/Age :

25.10.1968

Date of Appointment :

30.09.2013

DIN No.:

00088163

Other Directorship :

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24129DL2004PTC126157

MOSAIC INDIA PRIVATE LIMITED

Director

22/07/2005

22/07/2005

28/02/2013

Active

NO

2

U51420MH1949PLC007856

Arysta LifeScience India Limited

Managing director

30/09/2013

15/03/2013

-

Active

NO

3

U24100DL2005PTC227556

CHEMTURA CHEMICALS INDIA PRIVATE LIMITED

Additional director

10/08/2015

10/08/2015

-

Active

NO

 

 

Name :

Pradip Kumar Mazumdar

Designation :

Director

Address :

2, Mohan Bagan Lane, Kolkata - 700004, West Bengal, India

Date of Appointment :

30.09.2014

DIN No.:

00215260

Other Directorship :

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24210PN1995PTC136970

SYNGENTA CROP PROTECTION PRIVATE LIMITED

Director

05/05/2006

16/09/2001

14/08/2008

Active

NO

2

U24211DL1970NPL005200

CROP CARE FEDERATION OF INDIA

Director

28/09/2005

28/09/2005

01/04/2009

Active

NO

3

U91110DL1980GAP216937

CROPLIFE INDIA

Director

03/04/2009

03/04/2009

18/02/2013

Active

NO

4

U51420MH1949PLC007856

Arysta LifeScience India Limited

Director

30/09/2014

10/03/2011

-

Active

NO

5

U41000WB2011PTC165070

GEMS Aquapina Private Limited

Director

19/07/2011

19/07/2011

-

Strike off

NO

6

U74900HR2010FTC053632

Savannah Seeds Private Limited

Director

24/09/2012

05/03/2012

-

Active

NO

 

 

Name :

John Phillip Barnes

Designation :

Director

Address :

55, Morcellement Ramdanee, Black River - 00000, Mauritius

Date of Appointment :

12.08.2015

DIN No.:

07165035

 

 

Name :

Sujata Chattopadhyay

Designation :

Director

Address :

D-103, Jal Vayu Vihar, Powai, Mumbai - 400076, Maharashtra, India

Date of Appointment :

12.08.2015

DIN No.:

02336683

Other Directorship :

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

L67190MH1993PLC071117

CHOICE INTERNATIONAL LIMITED

Director

30/09/2009

23/09/2008

30/01/2010

Active

NO

2

U65990MH2010PTC198262

CHOICE CAPITAL ADVISORS PRIVATE LIMITED

Whole-time director

15/02/2011

19/02/2010

30/04/2014

Active

NO

3

U27200MH1988PLC050107

LOHA ISPAAT LIMITED

Director

20/05/2013

27/11/2012

23/06/2014

Active

NO

4

L74100AP1999PLC031191

STEEL EXCHANGE INDIA LIMITED

Additional director

27/03/2015

27/03/2015

-

Active

NO

5

L65990MH1990PLC056669

Vakrangee Limited

Additional director

31/03/2015

31/03/2015

-

Active

NO

6

L17120MH1981PLC025388

POLYGENTA TECHNOLOGIES LIMITED

Director

31/03/2015

31/03/2015

-

Active

NO

7

U51420MH1949PLC007856

Arysta LifeScience India Limited

Director

12/08/2015

31/03/2015

-

Active

NO

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 30.09.2014

 

Names of Shareholders

 

No. of Shares

Arysta LifeScience (Mauritius) Limited

 

2,877,094

Arysta LifeScience (Philippines) Inc.

 

1

Arysta LifeScience AgriMart Corporation

 

1

Arysta LifeScience (Thailand) Company

 

1

Grupo Bioquimico Mexicano SA de CV

 

1

Arysta LifeScience Canada Inc.

 

1

Arysta Lifescience Canada BC, Inc.

 

1

Total

 

2,877,100

 

 

Equity Share Break up (Percentage of Total Equity)

 

As on 30.09.2014

 

Category

Percentage

Foreign holdings( Foreign institutional investor(s), Foreign companie(s) Foreign financial institution(s), Non-resident Indian(s) or Overseas Corporate bodies or Others

100.00

Total

100.00

 

 

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Products related to Agrochemicals, Veterinary Chemicals and Pesticides.

 

 

Products :

Product Code

Description Of Product Or Service Category

  • 38089910

Pesticides

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

Products :

Finished Goods

Countries :

  • Middle East
  • European Countries
  • USA

 

 

Imports :

Products :

Raw Material

Countries :

France

 

 

Terms :

 

Selling :

Cash and Credit (30/60/90 Days)

 

 

Purchasing :

Cash and Credit (30/60/90 Days)

 

 

PRODUCTION STATUS – NOT AVAILABLE

 

 

GENERAL INFORMATION

 

Suppliers :

Company Name :

Not Divulged

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Maximum Limit Dealt :

Not Divulged

Experience :

Not Divulged

Remark :

Not Divulged

 

 

Customers :

End Users and OEM’s

 

Company Name :

Not Divulged

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Maximum Limit Dealt :

Not Divulged

Experience :

Not Divulged

Remark :

Not Divulged

 

 

No. of Employees :

500 (Approximately)

 

 

Bankers :

Banker Name :

Indian Overseas Bank

Branch :

Fort Branch, Mumbai – 400023, Maharashtra, India

Person Name (With Designation) :

Not Available

Contact Number :

Not Available

Name of Account Holder :

Not Available

Account Number :

Not Available

Account Since (Date/Year of Account Opening) :

Not Available

Average Balance Maintained :

Not Available

Credit Facilities Enjoyed (CC/OD/Term Loan) :

Not Available

Account Operation :

Not Available

Remark :

Not Available

 

 

Facilities :

SECURED LOANS

31.03.2014

Rs. In Million

31.03.2013

Rs. In Million

Long Term Borrowings

 

 

Rupee Term Loans from Banks

1.098

5.183

Loans and Advances

1.745

1.745

Total

2.843

6.928

 

Auditors :

 

Name :

S. V. Ghatalia and Associates LLP

Chartered Accountants

Address :

2nd Floor, Shivalik Ishaan, Near CN Vidhyalaya, Ambavadi, Ahmedabad – 380006, Gujarat, India

PAN No.:

ACHFS9181P

 

 

Collaborators :

Not Divulged

 

 

Membership :

Not Divulged

 

 

Holding Company :

  • Arysta Lifescience (Mauritius) Limited, Mauritius

 

Fellow Subsidiary Company :

  • Arysta Lifescience-France
  • Arysta Lifescience Corporation, Japan
  • Arysta Lifescience Vietnam Company, Limited, Viet Nam
  • Grupo Bioquimico  Mexicano, S.A. De, Mexico
  • Pt. Arys Ta Lifescience Tirta, Indonesia
  • Arysta Lifescience- South Africa Private Limited, South Africa
  • Arysta Lifescience (Thailand) Company Limited, Thailand

 

Ultimate Holding Company:

  • Arysta LifeScience Limited, Japan

 

 

CAPITAL STRUCTURE

 

AS ON 30.09.2014

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

5,000,000

Equity Shares

Rs. 10/- each

Rs. 50.000 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

2,877,100

Equity Shares

Rs. 10/- each

Rs. 28.771 Million

 

 

 

 

 

 

FINANCIAL DATA

[all figures are in Rupees Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2014

31.03.2013

31.03.2012

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

28.771

33.000

33.000

(b) Reserves & Surplus

823.773

1060.268

1051.344

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

852.544

1093.268

1084.344

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

2.843

6.928

1.745

(b) Deferred tax liabilities (Net)

0.000

2.067

5.960

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

20.719

15.389

3.987

Total Non-current Liabilities (3)

23.562

24.384

11.692

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

0.000

0.000

0.000

(b) Trade payables

496.835

385.497

265.425

(c) Other current liabilities

463.658

125.095

98.838

(d) Short-term provisions

6.949

5.002

6.815

Total Current Liabilities (4)

967.442

515.594

371.078

 

 

 

 

TOTAL

1843.548

1633.246

1467.114

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

115.197

110.887

98.431

(ii) Intangible Assets

8.619

9.417

0.000

(iii) Capital work-in-progress

3.205

0.000

2.724

(iv) Intangible assets under development

2.535

0.000

4.860

(b) Non-current Investments

0.552

0.499

0.471

(c) Deferred tax assets (net)

24.213

0.000

0.000

(d)  Long-term Loan and Advances

66.825

82.459

47.708

(e) Other Non-current assets

12.441

19.633

14.600

Total Non-Current Assets

233.587

222.895

168.794

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

102.615

76.981

(b) Inventories

578.602

425.200

500.689

(c) Trade receivables

675.394

506.336

466.076

(d) Cash and cash equivalents

282.014

339.405

231.715

(e) Short-term loans and advances

70.026

34.760

22.024

(f) Other current assets

3.925

2.035

0.835

Total Current Assets

1609.961

1410.351

1298.320

 

 

 

 

TOTAL

1843.548

1633.246

1467.114

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2014

31.03.2013

31.03.2012

 

SALES

 

 

 

 

 

Income

2305.238

1965.722

1953.085

 

 

Other Income

41.692

38.241

57.625

 

 

TOTAL SALES                        

2346.930

2003.963

2010.710

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Cost of Materials Consumed

1572.021

1246.803

1146.587

 

Purchase of Stock-in-trade

63.377

92.911

106.021

 

Changes in Inventories of finished goods, work-in-progress and stock-in-trade

(84.235)

33.404

(15.809)

 

Employee Benefits Expenses

173.667

146.683

109.083

 

Other Expenses

569.456

447.447

432.610

 

Exceptional Items

0.000

0.000

5.977

 

TOTAL EXPENSES

2294.286

1967.248

1784.469

 

 

 

 

 

 

PROFIT/(LOSS) BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

52.644

36.715

226.241

 

 

 

 

 

Less

FINANCIAL EXPENSES                                   

3.052

3.495

1.061

 

 

 

 

 

 

PROFIT/(LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION  

49.592

33.220

225.180

 

 

 

 

 

Less

DEPRECIATION/ AMORTISATION                    

23.684

22.661

13.630

 

 

 

 

 

 

PROFIT/(LOSS) BEFORE TAX 

25.908

10.559

211.550

 

 

 

 

 

Less

TAX                                                                 

6.319

1.636

62.755

 

 

 

 

 

 

PROFIT/(LOSS) AFTER TAX                

19.589

8.923

148.795

 

 

 

 

 

 

TOTAL EARNINGS

332.779

355.292

350.312

 

 

 

 

 

 

TOTAL IMPORTS

22.114

NA

NA

 

 

 

 

 

 

EARNINGS PER SHARE (RS.)

6.65

2.70

45.09

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

Particulars

 

31.03.2014

31.03.2013

31.03.2012

Current Maturities of Long term debt

3.955

3.658

3.658

Cash generated from operations

NA

NA

NA

Net cash flows from (used in) operations

(169.400)

184.730

182.189

Net cash flows from (used in) operating activities

(183.168)

142.470

139.929

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2014

31.03.2013

31.03.2012

Net Profit Margin

PAT / Sales

(%)

0.85

0.45

7.62

 

 

 

 

 

Operating Profit Margin

(PBDIT/Sales)

(%)

2.28

1.87

11.58

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets)

(%)

1.43

0.65

14.50

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.03

0.01

0.20

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

0.01

0.01

0.00

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.66

2.74

3.50

 

 

Particulars

 

 

 

31.03.2015

Sales Turnover (Approximately)

 

 

2500.000

 

The above information has been parted by Mr. Rajeev Gupta (Account Manager).

 

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2012

31.03.2013

31.03.2014

 

Rs. In Million

Rs. In Million

Rs. In Million

Share Capital

33.000

33.000

28.771

Reserves & Surplus

1051.344

1060.268

823.773

Net worth

1084.344

1093.268

852.544

 

 

 

 

long-term borrowings

1.745

6.928

2.843

Short term borrowings

0.000

0.000

0.000

CURRENT MATURITIES OF LONG-TERM DEBTS

3.658

3.658

3.955

Total borrowings

5.403

10.586

6.798

Debt/Equity ratio

0.005

0.010

0.008

 

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2012

31.03.2013

31.03.2014

 

Rs. In Million

Rs. In Million

Rs. In Million

Sales

1953.085

1965.722

2305.238

 

 --

0.647

17.272

 

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2012

31.03.2013

31.03.2014

 

Rs. In Million

Rs. In Million

Rs. In Million

Sales

1953.085

1965.722

2305.238

Profit

148.795

8.923

19.589

 

7.62%

0.45%

0.85%

 

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report (Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

Yes

5

Buyer visit details

--

6

Contact numbers

Yes

7

Name of the person contacted

Yes

8

Designation of contact person

Yes

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

No

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

Yes

16

No. of employees

Yes

17

Details of sister concerns

Yes

18

Major suppliers

No

19

Major customers

No

20

Banking Details

Yes

21

Banking facility details

No

22

Conduct of the banking account

--

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

Yes

26

Turnover of firm for last three years

Yes

27

Reasons for variation <> 20%

--

28

Estimation for coming financial year

Yes

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

No

32

Litigations that the firm/promoter involved in

--

33

Market information

--

34

Payments terms

Yes

35

Negative Reporting by Auditors in the Annual Report

No

 

Note: Registered office of the company has been shifted from Gupta Mills Estate Darukhana Reay Road, Mumbai - 400010, Maharashtra, India to the present address w.e.f. 13.02.2012.

 

 

OPERATIONS:

 

Despite the challenging economic scenario, the sales of the Company during the year under report registered good growth over the previous year. Sales, net of excise at Rs. 2305.240 million, represent an increase of 17.2%, over the previous year. Profit before tax for the year ended 31st March, 2014 stood at Rs. 25.910 million as compared to Rs. 10.560 million for the previous year which represents an increase of 145.3%. Profit after tax at Rs. 19.580 million during the year ended 31st March, 2014 was higher by 120% compared to the previous year. Arysta Proprietary product Orthene introduced last year by the Company has resulted a tremendous growth of 88% over the last year sales revenue. Orthene contributes 16% of the topline of the company in FY 2013-14. The company has introduced two new products which are part of Arysta LifeScience proprietary products i. e Pilatus and Vitalus in the Indian market in the current financial year. Company will be introducing more Arysta LifeScience proprietary products in the coming years.

 

 

CONTINGENT LIABILITIES:

 

A contingent liability is a possible obligation that arises from past events whose existence will be confirmed by the occurrence or non-occurrence of one or more uncertain future events beyond the control of the company or a present obligation that is not recognized because it is not probable that an outflow of resources will be required to settle the obligation. A contingent liability also arises in extremely rare cases where there is a liability that cannot be recognized because it cannot be measured reliably. The company does not recognize a contingent liability but discloses its existence in the financial statements.

 

 

INDEX OF CHARGE: NO CHARGES EXIST FOR COMPANY

 

 

FIXED ASSETS:

 

·         Land

·         Building

·         Plant and Machinery

·         Computer

·         Vehicles

·         Furniture and Fixture

 

 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                                       None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

Indian Rupees

US Dollar

1

Rs. 66.08

UK Pound

1

Rs. 100.32

Euro

1

Rs. 73.81

 

 

INFORMATION DETAILS

 

Information Gathered by :

PPT

 

 

Analysis Done by :

DIV

 

 

Report Prepared by :

SYL


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

6

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILITY

1~10

4

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

6

--CREDIT LINES

1~10

5

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

NO

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

 

 

 

TOTAL

 

47

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NB

NEW BUSINESS

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.